S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:NTCO

Natura &Co (NTCO) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$6.21
$6.97
52-Week Range
N/A
Volume
1.56 million shs
Average Volume
1.58 million shs
Market Capitalization
$4.56 billion
P/E Ratio
14.93
Dividend Yield
N/A
Price Target
$7.00
NTCO stock logo

About Natura &Co Stock (NYSE:NTCO)

Natura &Co Holding S.A. engages in the development, manufacturing, distribution, and resale of cosmetics, fragrances, and personal care products in Asia, North America, South America, Europe, the Middle East, Africa, and Oceania. It operates through Natura &Co Latam, Avon International, The Body Shop, and Aesop segments. The company offers fragrances, makeup, body and facial care, sunscreen, soaps, deodorants, body oils, hair care, and gifts products. It also provides decorative, houseware, entertainment and leisure, and children's products, as well as jewelry, watches, clothing, footwear, and accessories. The company markets its products under the Natura, Avon, The Body Shop, and Aesop brand names through signature and department stores, e-commerce, direct selling, business-to-business, franchises, physical stores, and retail markets. Natura &Co Holding S.A. was founded in 1969 and is headquartered in São Paulo, Brazil.

NTCO Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
NTCO May 2024 7.500 call
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Natura: Strategic Confusion And Subpar Execution
Avon International realiza transição de liderança
Leadership transition in Avon International
Natura: Multiple Positives, Reiterate Buy
See More Headlines
Receive NTCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natura &Co and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/29 Dividend
3/21/2024
Today
4/19/2024
Dividend Payable
4/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
N/A
Fax
N/A
Employees
32,398
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-553,910,000.00
Pretax Margin
-8.48%

Debt

Sales & Book Value

Annual Sales
$7.04 billion
Book Value
$6.26 per share

Miscellaneous

Free Float
692,869,000
Market Cap
$4.56 billion
Optionable
Optionable
Beta
2.02
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Antonio Luiz da Cunha Seabra (Age 82)
    Founder & Co-Chairman of the Board
  • Mr. Fabio Colletti Barbosa (Age 70)
    Chief Executive Officer
  • Mr. Guilherme Strano Castellan (Age 41)
    CFO, Investor Relations Officer & Member of Executive Board
  • Mr. Moacir Salzstein (Age 66)
    Corporate Governance Officer & Member of Executive Board
  • Mr. Joao Paulo Brotto Gonçalves Ferreira (Age 57)
    CEO of Latin America & Member of Executive Board
  • Mr. Itamar Gaino Filho (Age 48)
    Chief Legal & Compliance Officer and Member of Executive Board
  • Mr. Daniel Madureira Gonzaga
    Science & Technology Director
  • Ms. Andrea Figueiredo Teixeira Álvares
    Executive Officer of Marketing, Innovation & Sustainability
  • Mr. Flavio Pesiguelo
    Vice President of People & Culture
  • Mr. Renato Abramovich
    Managing Director of Mexico

NTCO Stock Analysis - Frequently Asked Questions

Should I buy or sell Natura &Co stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Natura &Co in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NTCO shares.
View NTCO analyst ratings
or view top-rated stocks.

What is Natura &Co's stock price target for 2024?

1 analysts have issued 1-year target prices for Natura &Co's stock. Their NTCO share price targets range from $7.00 to $7.00. On average, they expect the company's share price to reach $7.00 in the next twelve months.
View analysts price targets for NTCO
or view top-rated stocks among Wall Street analysts.

How often does Natura &Co pay dividends? What is the dividend yield for Natura &Co?

Natura &Co declared a dividend on Saturday, March 16th. Investors of record on Friday, March 22nd will be paid a dividend of $0.2506 per share on Monday, April 29th. This represents a yield of 3.36%. The ex-dividend date is Thursday, March 21st.
Read our dividend analysis for NTCO
.

This page (NYSE:NTCO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners